Home>Topics>Stocks>NPS Pharmaceuticals

NPS Pharmaceuticals NPSP

  1. All
  2. Commentary
  3. Headlines
    1. Midday Gainers / Losers

      Headlines

      Mon, 15 Sep 2014

      PPP +10% . VNET +9% . USAT +9% . FHCO +9% . Top 10 Losers: NETE -33% . RATE -17% . LOXO -17% . SYN -15% . MSN -15% . SCOK -15% . NPSP -14% . MGPI -14% . CTP -14% . LOXO -15% . RADA -12% . Post your comment!

    2. Premarket Gainers / Losers

      Headlines

      Mon, 15 Sep 2014

      Gainers: AVNR +44% . ALR +20% . OTIV +11% . ETAK +7% . TAP +7% . HALO +6% . Losers: NPSP -13% . NETE -9% . TEX -8% . MDU -6% . Post your comment!

    3. NPS off premarket

      Headlines

      Mon, 15 Sep 2014

      NPS Pharmaceuticals (NASDAQ: NPSP ) is set for a gap down at the open. Shares are off 8% premarket on good volume. On Friday, the an FDA Advisory Committee voted 8-5 in favor of approval of Natpara for the long-term treatment of hypoparathyroidism. Post your comment!

    4. U.S. FDA panel recommends approval of NPS hormone replacement drug

      Headlines

      Fri, 12 Sep 2014

      Sept 12 (Reuters) - A panel of outside advisers to the U.S. Food and Drug Administration on Friday voted 8-5 to recommend approval for Natpara, a hormone replacement therapy developed by NPS Pharmaceuticals Inc.

    5. Positive Ad Comm vote for Natpara

      Headlines

      Fri, 12 Sep 2014

      The FDA's Endocrinologic and Metabolic Drugs Advisory Committee votes 8-5 in favor of approval for NPS Pharmaceuticals ' ( NPSP ) Natpara for the long-term treatment of hypoparathyroidism. 2 comments!

    6. Trading halt for NPS Pharma

      Headlines

      Fri, 12 Sep 2014

      NASDAQ halts trading in NPS Pharmaceuticals (NASDAQ: NPSP ) pending news from today's Ad Comm meeting reviewing the company's Natpara (rhPTH [1-84]) BLA. Post your comment!

    7. Midday Gainers / Losers

      Headlines

      Wed, 10 Sep 2014

      Top 10 Gainers: NETE +136% . SYMX +24% . OTIV +23% . NPSP +21% . RCPT +20% . MTSL +21% . INVT +17% . LE +16% . AVNR +14% . MNOV +14 . Top 10 Losers: OTC:RXII -29% . PULS

    8. Investors come back to NPSP

      Headlines

      Wed, 10 Sep 2014

      The briefing docs for Friday's Ad Comm meeting apparently don't contain any smoking guns or red flags for NPS Pharmaceuticals (NASDAQ: NPSP ). Shares are up 20% premarket on robust volume. 1 comment!

    9. Premarket Gainers / Losers

      Headlines

      Wed, 10 Sep 2014

      Gainers: MNOV +21% . NPSP +18% . MNDL +16% . CAMT +14% . DRL +13% . OTIV +13% . LUNA +10% . LE +8% . VNET +7% . BDBD +6% . Losers: AU -12% . GTAT -8% . SCOK -7% . PULS -6% . WPCS -6% . Post your comment!

    10. US STOCKS-NPS soars after preliminary review from FDA

      Headlines

      Wed, 10 Sep 2014

      NEW YORK, Sept 10 (Reuters) - NPS Pharmaceuticals Inc rose sharply in premarket trading on Wednesday, after a preliminary review by the Food and Drug Administration said the company

    « Prev1234Next »
    Content Partners